全文获取类型
收费全文 | 46364篇 |
免费 | 5202篇 |
国内免费 | 84篇 |
专业分类
耳鼻咽喉 | 638篇 |
儿科学 | 1398篇 |
妇产科学 | 1282篇 |
基础医学 | 7191篇 |
口腔科学 | 1140篇 |
临床医学 | 6231篇 |
内科学 | 8626篇 |
皮肤病学 | 642篇 |
神经病学 | 3653篇 |
特种医学 | 1632篇 |
外国民族医学 | 1篇 |
外科学 | 6247篇 |
综合类 | 945篇 |
一般理论 | 29篇 |
预防医学 | 4764篇 |
眼科学 | 715篇 |
药学 | 3681篇 |
中国医学 | 63篇 |
肿瘤学 | 2772篇 |
出版年
2021年 | 628篇 |
2020年 | 420篇 |
2019年 | 704篇 |
2018年 | 845篇 |
2017年 | 622篇 |
2016年 | 759篇 |
2015年 | 812篇 |
2014年 | 1107篇 |
2013年 | 1679篇 |
2012年 | 2146篇 |
2011年 | 2190篇 |
2010年 | 1289篇 |
2009年 | 1172篇 |
2008年 | 1910篇 |
2007年 | 2000篇 |
2006年 | 1960篇 |
2005年 | 1897篇 |
2004年 | 1820篇 |
2003年 | 1753篇 |
2002年 | 1789篇 |
2001年 | 1574篇 |
2000年 | 1600篇 |
1999年 | 1400篇 |
1998年 | 711篇 |
1997年 | 588篇 |
1996年 | 525篇 |
1995年 | 530篇 |
1994年 | 510篇 |
1993年 | 443篇 |
1992年 | 1131篇 |
1991年 | 1071篇 |
1990年 | 1043篇 |
1989年 | 978篇 |
1988年 | 901篇 |
1987年 | 927篇 |
1986年 | 892篇 |
1985年 | 909篇 |
1984年 | 716篇 |
1983年 | 610篇 |
1982年 | 447篇 |
1981年 | 362篇 |
1980年 | 377篇 |
1979年 | 583篇 |
1978年 | 446篇 |
1977年 | 370篇 |
1976年 | 381篇 |
1974年 | 379篇 |
1973年 | 333篇 |
1972年 | 338篇 |
1971年 | 304篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Pulmonary clearance of UICC amosite fibres inhaled by rats during chronic exposure at low concentration.
下载免费PDF全文
![点击此处可从《Occupational and environmental medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A D Jones C H McMillan A M Johnston C McIntosh H Cowie R E Bolton G Borzucki J H Vincent 《Occupational and environmental medicine》1988,45(5):300-304
Clearance of UICC amosite asbestos from the lungs during chronic--that is, repeated--exposure was investigated by using the scanning electron microscope to measure lung burdens from rats which had inhaled amosite asbestos at an approximately constant concentration of 0.1 mg/m3 or, equivalently, 20 fibres/ml for seven hours a day, five days a week for up to 18 months. The lung burdens were compared with previous results for higher exposure concentrations of 1 and 10 mg/m3. Those previous lung burdens had been measured using other analytical methods (infrared spectrophotometry) that were not suitable for the new lower lung burdens. Taken together, these results showed lung burdens rising pro rata with exposure concentration and exposure time. This accumulation of lung burden has been described by a kinetic model that takes account of the sequestration of material at locations in the lung from where it cannot be cleared. Unlike some earlier models in which lung burdens eventually reach a plateau with equilibrium between deposition and clearance during chronic exposure, this sequestration model shows lung burdens continuing to rise with exposure time. The latest results reported here support the application of such a model to lower exposure concentrations closer to those of asbestos in workplaces. 相似文献
82.
83.
B F Trump T W Jones K A Elliget M W Smith P C Phelps A Maki I K Berezesky 《Renal failure》1990,12(3):183-191
Cellular toxicity and cellular carcinogenesis are closely linked. In the kidney, this relationship has been emphasized by the recent discovery of a number of putatively non-mutagenic chemicals that result in acute and chronic toxicity and ultimately in carcinogenesis, especially in the male rat. Many, but not all such compounds, result in renal PTE phagolysosomal overload. At the same time, known metabolites of other carcinogens, e.g., HCBD and FBPA, result in acute renal injury and/or necrosis, followed by chronic tubular disease, interstitial nephritis, and ultimately carcinogenesis. A series of cell mechanisms have been suggested that lead from acute cell injury to altered control of cell division. These mechanisms appear to involve ion deregulation, (especially [Ca2+]i) resulting from a variety of continued injuries, (e.g., oxidative stress from inflammatory cells) and ultimately leading to altered gene expression. 相似文献
84.
85.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
86.
Shirley L. Jones RNC MS 《Journal of obstetric, gynecologic, and neonatal nursing : JOGNN / NAACOG》1996,25(9):777-783
Advances in human genetics are rapidly changing the scope of information and care that can be provided to health care consumers. By the year 2005 it is expected that the entire human genome will be mapped and all 70,000–100,000 genes will be identified. Currently, there are more than 5,000 known single-gene disorders. With the movement of specialized health services into the primary care setting, nurses increasingly will need to be knowledgeable about genetic disorders, screening/diagnostic tests, and implications for health care. In addition, the management of genetic information raises issues of informed consent, privacy and confidentiality, truth telling and disclosure, and nondiscrimination. 相似文献
87.
88.
89.
Williams C. A. Jones H. D. Freeman R. W. Wernke M. J. Williams P. L. Roberts S. M. James R. C. 《Regulatory toxicology and pharmacology : RTP》1994,20(3)
Reference doses (RfDs) and reference concentrations (RfCs) developed by the United States Environmental Protection Agency (USEPA) are typically used in the quantitation of risk of potential adverse human health effects from exposure to environmental chemicals. For a large number of chemicals, however, USEPA RfDs and RfCs have not yet been determined. Thus, for risk assessments that involve a large number of chemicals, there is insufficient toxicity information with which to evaluate potential adverse human health effects for all chemicals present at a particular site. Due to this insufficiency, the risk assessor must either (1) ignore potential exposures on the assumption that omitting these exposures does not significantly alter decisions concerning the remediation of the site or (2) undertake a lengthy and costly analysis to generate the necessary RfDs or RfCs. A potential solution to this problem is to develop estimated permissible concentrations (EPCs), values which represent permissible environmental concentrations or related acceptable daily dosages derived from occupational exposure limits. In the present analysis, acceptable daily dosages determined using the EPC method were compared to USEPA RfDs or RfCs which were converted to dosages based on standard exposure assumptions. Based on a comparative analysis of EPCs and USEPA reference values for 103 chemicals, it was found that EPC daily dosages represent a reasonably conservative surrogate value when USEPA or state reference values are unavailable. Given that there are hundreds of chemicals with occupational exposure limits but no state or USEPA reference values, acceptance of the EPC methodology would provide an interim solution for the problem of insufficient toxicity information for a substantial number of environmental chemical contaminants. 相似文献
90.